Cell
Volume 183, Issue 2, 15 October 2020, Pages 347-362.e24
ArticleA Phase Ib Trial of Personalized Neoantigen Therapy Plus Anti-PD-1 in Patients with Advanced Melanoma, Non-small Cell Lung Cancer, or Bladder Cancer
Under an Elsevier user license
open archive
Graphical Abstract
Keywords
immunotherapy
epitope spread
metastatic cancer
NEO-PV-01
cancer vaccine
T cell
neoantigen
personalized vaccine
checkpoint inhibitor
anti-PD-1
Cited by (0)
- 11
Lead Contact
© 2020 Elsevier Inc.